Clinical Study
Study evaluates zinc in treatment of ADHD
Symptoms of attention-deficit/hyperactivity (ADHD) disorder are often treated with methylphenidate and amphetamine. This study evaluates the of zinc glycinate as a cofactor for metabolism relative to neurotransmitters, prostaglandins, and melatonin, which indirectly affect dopamine metabolism. One of the findings from the study was a reduction of the dose of stimulant (37%) when a using 30 mg. of zinc per day. This suggests the need to further research the use of zinc with optimal doses of stimulants relative to ADHD.